BioCentury | Jan 14, 2021
Deals

Jan. 13 Quick Takes: Takeda, KSQ enter immunotherapy deal; plus Taysha, Cardea, Esperion-Serometrix, Paion-La Jolla and more

...program through Serometrix dealEsperion Therapeutics Inc. (NASDAQ:ESPR) in-licensed a preclinical oral PCSK9 inhibitor program from Serometrix LLC...
BioCentury | Apr 20, 2017
Product R&D

Stalling translation

...but was shut down the next year when the company failed to find suitable molecules. Serometrix LLC...
...Ribometrix Inc., Chapel Hill, N.C. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Serometrix LLC...
BioCentury | Oct 5, 2015
Emerging Company Profile

Picking a PCSK9

...and antagonists of the PCSK9/LDL receptor interaction and plans to begin IND-enabling studies next year. Serometrix LLC...
...Pharmaceuticals Inc. (NASDAQ:REGN), Tarrytown, N.Y. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Serometrix LLC...
BioCentury | Sep 21, 2015
Product Development

Alnylam's lipid sync

...approaches to inhibiting PCSK9. Pfizer Inc. , Liphorus Pharmaceuticals Inc. , Shifa Biomedical Corp. and Serometrix LLC...
...NYSE:PFE), New York, N.Y. Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), Tarrytown, N.Y. Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Serometrix LLC...
BioCentury | Feb 6, 2014
Targets & Mechanisms

PCSK9 peptide inhibitors

...However, these compounds all require parenteral administration, and orally available inhibitors still lag far behind. Serometrix LLC...
...and Shifa Biomedical Corp. have disclosed preclinical small molecule programs for oral inhibitors of PCSK9. Serometrix...
...and AMP-activated protein kinase ( AMPK ) activator, in Phase IIb testing to treat hypercholesterolemia. Serometrix...
BioCentury | Apr 30, 2012
Product Development

PCSK9 bandwagon

...the Holy Grail is always going to be an orally active small molecule," she said. Serometrix LLC...
...Inc. , Richmond Va. Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), Tarrytown, N.Y. Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Serometrix LLC...
BioCentury | Apr 30, 2012
Product Development

Beyond statins: LDL diversity

...oligonucleotide SC Preclin Shifa Biomedical Corp. NA Small molecule Oral Preclin (preclin POC by YE12) Serometrix LLC...
Items per page:
1 - 7 of 7
BioCentury | Jan 14, 2021
Deals

Jan. 13 Quick Takes: Takeda, KSQ enter immunotherapy deal; plus Taysha, Cardea, Esperion-Serometrix, Paion-La Jolla and more

...program through Serometrix dealEsperion Therapeutics Inc. (NASDAQ:ESPR) in-licensed a preclinical oral PCSK9 inhibitor program from Serometrix LLC...
BioCentury | Apr 20, 2017
Product R&D

Stalling translation

...but was shut down the next year when the company failed to find suitable molecules. Serometrix LLC...
...Ribometrix Inc., Chapel Hill, N.C. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Serometrix LLC...
BioCentury | Oct 5, 2015
Emerging Company Profile

Picking a PCSK9

...and antagonists of the PCSK9/LDL receptor interaction and plans to begin IND-enabling studies next year. Serometrix LLC...
...Pharmaceuticals Inc. (NASDAQ:REGN), Tarrytown, N.Y. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Serometrix LLC...
BioCentury | Sep 21, 2015
Product Development

Alnylam's lipid sync

...approaches to inhibiting PCSK9. Pfizer Inc. , Liphorus Pharmaceuticals Inc. , Shifa Biomedical Corp. and Serometrix LLC...
...NYSE:PFE), New York, N.Y. Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), Tarrytown, N.Y. Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Serometrix LLC...
BioCentury | Feb 6, 2014
Targets & Mechanisms

PCSK9 peptide inhibitors

...However, these compounds all require parenteral administration, and orally available inhibitors still lag far behind. Serometrix LLC...
...and Shifa Biomedical Corp. have disclosed preclinical small molecule programs for oral inhibitors of PCSK9. Serometrix...
...and AMP-activated protein kinase ( AMPK ) activator, in Phase IIb testing to treat hypercholesterolemia. Serometrix...
BioCentury | Apr 30, 2012
Product Development

PCSK9 bandwagon

...the Holy Grail is always going to be an orally active small molecule," she said. Serometrix LLC...
...Inc. , Richmond Va. Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), Tarrytown, N.Y. Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Serometrix LLC...
BioCentury | Apr 30, 2012
Product Development

Beyond statins: LDL diversity

...oligonucleotide SC Preclin Shifa Biomedical Corp. NA Small molecule Oral Preclin (preclin POC by YE12) Serometrix LLC...
Items per page:
1 - 7 of 7